Blood-Brain-Barrier (BBB) Models

About Tempo Bioscience

Tempo Bioscience is a private, early-stage biotech firm founded in 2020, specializing in the development of advanced cell-based assay technologies and disease models. The company leverages human primary cells, iPSCs, and 3D culture techniques to create patient-relevant in vitro systems for drug discovery and preclinical research, with a focus on complex biological barriers and organ-specific toxicity. Operating primarily as a platform and services provider, Tempo supports pharmaceutical and biotech partners in adopting New Approach Methodologies (NAMs) to reduce reliance on animal models. Its current expansion into human liver and blood-brain-barrier models positions it in the growing market for human-relevant predictive assays.

Therapeutic Areas

Other CNS Drug Development Drugs